Venture Life Group plc (AIM: VLG)

Market Cap	47.01M
Revenue (ttm)	51.41M
Net Income (ttm)	742.00K
Shares Out	127.05M
EPS (ttm)	0.01
PE Ratio	67.64
Forward PE	6.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,817
Open	37.00
Previous Close	37.25
Day's Range	36.50 - 37.00
52-Week Range	33.00 - 51.29
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About Venture Life Group

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 165
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: VLG

Financial Performance

In 2023, Venture Life Group's revenue was 51.41 million, an increase of 16.89% compared to the previous year's 43.98 million. Earnings were 921,000, an increase of 77.12%.